Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Tourmaline Bio Inc. (NASDAQ : TRML) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.
Quote
| Last: | $47.98 |
|---|---|
| Change Percent: | 0.27% |
| Open: | $47.98 |
| Close: | $47.85 |
| High: | $48 |
| Low: | $47.98 |
| Volume: | 458,710 |
| Last Trade Date Time: | 10/27/2025 12:45:07 pm |
Stock Data
| Market Cap: | $1,232,715,019 |
|---|---|
| Float: | 15,877,822 |
| Insiders Ownership: | N/A |
| Institutions: | 136 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.talaristx.com |
| Country: | US |
| City: | New York |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Tourmaline Bio Inc. (NASDAQ: TRML).
